Overview

Comparison of the Effect on the Glucose Infusion Rates Between Inhaled Technosphere Insulin and a Subcutaneous Injection of Regular Human Insulin

Status:
Completed

Trial end date:
2000-06-01

Target enrollment:

Participant gender:

Summary

A prospective, single center, open randomized, six way crossover study comparing the dose response effect of four different doses of Technosphere Insulin after pulmonary function delivery in comparison to s.c. injection of two different doses of regular human insulin.

Phase:

Phase 1

Details

Lead Sponsor:

Mannkind Corporation

Treatments:

Insulin
Insulin, Globin Zinc